{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:19:06Z","timestamp":1778048346819,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"TAEJOON Pharmaceutical Co., Ltd.","award":["06-2021-0335"],"award-info":[{"award-number":["06-2021-0335"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10702-x","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:28:48Z","timestamp":1753140528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of gadobutrol and meglumine gadoterate for dynamic contrast-enhanced MRI of pituitary macroadenomas"],"prefix":"10.1038","volume":"15","author":[{"given":"Kihwan","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Jung","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chae-Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Yeong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hyun","family":"Baik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Sunwoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Se","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheolkyu","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"10702_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109125","volume":"129","author":"YQ Liu","year":"2020","unstructured":"Liu, Y. Q. et al. Preoperative vascular heterogeneity and aggressiveness assessment of pituitary macroadenoma based on dynamic contrast-enhanced MRI texture analysis. Eur. J. Radiol. 129, 109125 (2020).","journal-title":"Eur. J. Radiol."},{"key":"10702_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11102-007-0048-4","volume":"10","author":"AM Manuchehri","year":"2007","unstructured":"Manuchehri, A. M. et al. Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). Pituitary 10, 261\u2013266 (2007).","journal-title":"Pituitary"},{"key":"10702_CR3","first-page":"4237","volume":"17","author":"J Zhai","year":"2019","unstructured":"Zhai, J., Zheng, W., Zhang, Q., Wu, J. & Zhang, X. Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging. Oncol. Lett. 17, 4237\u20134244 (2019).","journal-title":"Oncol. Lett."},{"key":"10702_CR4","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1530\/EC-21-0386","volume":"10","author":"R Al Argan","year":"2021","unstructured":"Al Argan, R., Ramadhan, A., Agnihotram, R. V., Chankowsky, J. & Rivera, J. Baseline MRI findings as predictors of hypopituitarism in patients with non-functioning pituitary adenomas. Endocr. Connect 10, 1445\u20131454 (2021).","journal-title":"Endocr. Connect"},{"key":"10702_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","volume":"21","author":"G Ntali","year":"2018","unstructured":"Ntali, G. & Wass, J. A. Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21, 111\u2013118 (2018).","journal-title":"Pituitary"},{"key":"10702_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11604-020-00942-4","volume":"38","author":"K Kamimura","year":"2020","unstructured":"Kamimura, K. et al. Quantitative pharmacokinetic analysis of high-temporal-resolution dynamic contrast-enhanced MRI to differentiate the normal-appearing pituitary gland from pituitary macroadenoma. Jpn. J. Radiol. 38, 649\u2013657 (2020).","journal-title":"Jpn. J. Radiol."},{"key":"10702_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s00330-011-2291-3","volume":"22","author":"HB Lee","year":"2012","unstructured":"Lee, H. B. et al. Usefulness of the dynamic gadolinium-enhanced magnetic resonance imaging with simultaneous acquisition of coronal and sagittal planes for detection of pituitary microadenomas. Eur. Radiol. 22, 514\u2013518 (2012).","journal-title":"Eur. Radiol."},{"key":"10702_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiology.177.1.2399335","volume":"177","author":"Y Miki","year":"1990","unstructured":"Miki, Y. et al. Pituitary adenomas and normal pituitary tissue: enhancement patterns on Gadopentetate-enhanced MR imaging. Radiology 177, 35\u201338 (1990).","journal-title":"Radiology"},{"key":"10702_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jmri.23675","volume":"36","author":"N Zhang","year":"2012","unstructured":"Zhang, N. et al. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J. Magn. Reson. Imaging 36, 355\u2013363 (2012).","journal-title":"J. Magn. Reson. Imaging"},{"key":"10702_CR10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/mrm.22861","volume":"66","author":"SP Sourbron","year":"2011","unstructured":"Sourbron, S. P. & Buckley, D. L. On the scope and interpretation of the Tofts models for DCE-MRI. Magn. Reson. Med. 66, 735\u2013745 (2011).","journal-title":"Magn. Reson. Med."},{"key":"10702_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11102-007-0044-8","volume":"10","author":"T Sathyapalan","year":"2007","unstructured":"Sathyapalan, T., Lowry, M., Turnbull, L. W., Rowland-Hill, C. & Atkin, S. L. Mechanism of action of octreotide in acromegalic tumours in vivo using dynamic contrast-enhanced magnetic resonance imaging. Pituitary 10, 233\u2013236 (2007).","journal-title":"Pituitary"},{"key":"10702_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1148\/radiol.2019181296","volume":"290","author":"DP Barboriak","year":"2019","unstructured":"Barboriak, D. P. et al. Interreader variability of dynamic contrast-enhanced MRI of recurrent glioblastoma: The multicenter ACRIN 6677\/RTOG 0625 study. Radiology 290, 467\u2013476 (2019).","journal-title":"Radiology"},{"key":"10702_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiol.12122447","volume":"266","author":"V Goh","year":"2013","unstructured":"Goh, V., Schaeffter, T. & Leach, M. Reproducibility of dynamic contrast-enhanced MR imaging: Why we should care. Radiology 266, 698\u2013700 (2013).","journal-title":"Radiology"},{"key":"10702_CR14","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1007\/s00330-019-06321-6","volume":"29","author":"CH Lee","year":"2019","unstructured":"Lee, C. H., Vellayappan, B., Taupitz, M., Hamm, B. & Asbach, P. Dynamic contrast-enhanced MR imaging of the prostate: Intraindividual comparison of gadoterate meglumine and gadobutrol. Eur. Radiol. 29, 6982\u20136990 (2019).","journal-title":"Eur. Radiol."},{"key":"10702_CR15","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3174\/ajnr.A5316","volume":"38","author":"KR Maravilla","year":"2017","unstructured":"Maravilla, K. R. et al. Comparison of gadoterate meglumine and gadobutrol in the MRI diagnosis of primary brain tumors: A double-blind randomized controlled intraindividual crossover study (the REMIND Study). AJNR Am. J. Neuroradiol. 38, 1681\u20131688 (2017).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10702_CR16","first-page":"1774","volume":"60","author":"M Bendszus","year":"2024","unstructured":"Bendszus, M. et al. MRI gadolinium-based contrast media: Meeting radiological, clinical, and environmental needs. J. Magn. Reson. Imaging 60, 1774\u20131785 (2024).","journal-title":"J. Magn. Reson. Imaging"},{"key":"10702_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40261-018-0674-9","volume":"38","author":"LJ Scott","year":"2018","unstructured":"Scott, L. J. Gadobutrol: a review in contrast-enhanced MRI and MRA. Clin. Drug Investig. 38, 773\u2013784 (2018).","journal-title":"Clin. Drug Investig."},{"key":"10702_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neurad.2020.06.005","volume":"49","author":"A Del Poggio","year":"2022","unstructured":"Del Poggio, A. et al. Diagnostic efficacy and safety of gadoteridol compared to gadobutrol and gadoteric acid in a large sample of CNS MRI studies at 1.5T. J. Neuroradiol. 49, 73\u201379 (2022).","journal-title":"J. Neuroradiol."},{"key":"10702_CR19","volume":"23","author":"H Hashemi","year":"2021","unstructured":"Hashemi, H. et al. Comparison of gadovist and magnevist in brain magnetic resonance imaging of multiple sclerosis patients with an acute attack. Iran Red Crescent Med. J. 23, e192 (2021).","journal-title":"Iran Red Crescent Med. J."},{"key":"10702_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109682","volume":"139","author":"J Xie","year":"2021","unstructured":"Xie, J. et al. Comparison of inner ear MRI enhancement in patients with Meniere\u2019s disease after intravenous injection of gadobutrol, gadoterate meglumine, or gadodiamide. Eur. J. Radiol. 139, 109682 (2021).","journal-title":"Eur. J. Radiol."},{"key":"10702_CR21","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.3174\/ajnr.A6792","volume":"41","author":"JE Park","year":"2020","unstructured":"Park, J. E., Kim, J. Y., Kim, H. S. & Shim, W. H. Comparison of dynamic contrast-enhancement parameters between gadobutrol and gadoterate meglumine in posttreatment glioma: A prospective intraindividual study. AJNR Am. J. Neuroradiol. 41, 2041\u20132048 (2020).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10702_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jmri.10399","volume":"18","author":"BM Dale","year":"2003","unstructured":"Dale, B. M., Jesberger, J. A., Lewin, J. S., Hillenbrand, C. M. & Duerk, J. L. Determining and optimizing the precision of quantitative measurements of perfusion from dynamic contrast enhanced MRI. J. Magn. Reson. Imaging 18, 575\u2013584 (2003).","journal-title":"J. Magn. Reson. Imaging"},{"key":"10702_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/RLI.0000000000000645","volume":"55","author":"G Knobloch","year":"2020","unstructured":"Knobloch, G. et al. Signal enhancement and enhancement kinetics of gadobutrol, gadoteridol, and gadoterate meglumine in various body regions: a comparative animal study. Invest Radiol. 55, 367\u2013373 (2020).","journal-title":"Invest Radiol."},{"key":"10702_CR24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.endonu.2013.04.009","volume":"61","author":"R C\u00e1mara-G\u00f3mez","year":"2014","unstructured":"C\u00e1mara-G\u00f3mez, R. Non-functioning pituitary tumors: 2012 update. Endocrinol. Nutr. 61, 160\u2013170 (2014).","journal-title":"Endocrinol. Nutr."},{"key":"10702_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s11102-020-01044-0","volume":"23","author":"ICM Pelsma","year":"2020","unstructured":"Pelsma, I. C. M. et al. Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: Visual outcomes and timing of intervention. Pituitary 23, 417\u2013429 (2020).","journal-title":"Pituitary"},{"key":"10702_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12022-009-9091-1","volume":"20","author":"E Jasek","year":"2009","unstructured":"Jasek, E. et al. Microvessel density and area in pituitary microadenomas. Endocr. Pathol. 20, 221\u2013226 (2009).","journal-title":"Endocr. Pathol."},{"key":"10702_CR27","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.23.30036","volume":"223","author":"J Starekova","year":"2024","unstructured":"Starekova, J., Pirasteh, A. & Reeder, S. B. Update on gadolinium-based contrast agent safety, from the AJR special series on contrast media. AJR Am. J. Roentgenol. 223, e2330036 (2024).","journal-title":"AJR Am. J. Roentgenol."},{"key":"10702_CR28","doi-asserted-by":"publisher","first-page":"1426781","DOI":"10.3389\/fendo.2024.1426781","volume":"15","author":"B Zheng","year":"2024","unstructured":"Zheng, B., Zhao, Z., Zheng, P., Liu, Q. & Li, S. The current state of MRI-based radiomics in pituitary adenoma: promising but challenging. Front Endocrinol. (Lausanne) 15, 1426781 (2024).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10702_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.crad.2012.01.001","volume":"67","author":"TA Abele","year":"2012","unstructured":"Abele, T. A., Yetkin, Z. F., Raisanen, J. M., Mickey, B. E. & Mendelsohn, D. B. Non-pituitary origin sellar tumours mimicking pituitary macroadenomas. Clin Radiol 67, 821\u2013827 (2012).","journal-title":"Clin Radiol"},{"key":"10702_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.crad.2006.12.001","volume":"62","author":"SH Choi","year":"2007","unstructured":"Choi, S. H. et al. Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin. Radiol. 62, 453\u2013462 (2007).","journal-title":"Clin. Radiol."},{"key":"10702_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3348\/jkrs.2006.55.1.1","volume":"55","author":"HS Kim","year":"2006","unstructured":"Kim, H. S. et al. MR differentiation of craniopharyngioma from pituitary macroadenoma. J. Korean Radiol. Soc. 55, 1\u20138 (2006).","journal-title":"J. Korean Radiol. Soc."},{"key":"10702_CR32","first-page":"621","volume":"31","author":"SL Taylor","year":"1992","unstructured":"Taylor, S. L., Barakos, J. A., Harsh, G. R. & Wilson, C. B. Magnetic resonance imaging of tuberculum sellae meningiomas: Preventing preoperative misdiagnosis as pituitary macroadenoma. Neurosurgery 31, 621\u2013627 (1992).","journal-title":"Neurosurgery"},{"key":"10702_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s002340050698","volume":"41","author":"P Cappabianca","year":"1999","unstructured":"Cappabianca, P., Cirillo, S., Alfieri, A., D\u2019Amico, A. & Maiuri, F. Pituitary macroadenoma and diaphragma sellae meningioma: differential diagnosis on MRI. Neuroradiology 41, 22\u201326 (1999).","journal-title":"Neuroradiology"},{"key":"10702_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3174\/ajnr.A8302","volume":"45","author":"S Yuzkan","year":"2024","unstructured":"Yuzkan, S., Erkan, B., Dogukan, F. M., Ozkiziltan, U. & Balsak, S. Distinguishing pituitary metastasis and pituitary neuroendocrine tumors through conventional MR imaging and clinical features. AJNR Am. J. Neuroradiol. 45, 1063\u20131069 (2024).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10702_CR35","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s11102-020-01122-3","volume":"24","author":"Q Fang","year":"2021","unstructured":"Fang, Q. et al. Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: A systematic review and meta-analysis. Pituitary 24, 888\u2013898 (2021).","journal-title":"Pituitary"},{"key":"10702_CR36","doi-asserted-by":"publisher","first-page":"1222581","DOI":"10.3389\/fonc.2023.1222581","volume":"13","author":"X Wang","year":"2023","unstructured":"Wang, X., Wang, B., Cheng, G., You, Y. & Tao, C. Intradural fat graft packing is not indispensable in preventing postoperative cerebrospinal fluid leakage in endoscopic endonasal pituitary adenoma surgeries. Front. Oncol. 13, 1222581 (2023).","journal-title":"Front. Oncol."},{"key":"10702_CR37","first-page":"320","volume":"12","author":"C Petry","year":"2019","unstructured":"Petry, C. et al. Evaluation of the potential of the Ki-67 index to predict tumor evolution in patients with pituitary adenoma. Int. J. Clin. Exp. Pathol. 12, 320\u2013326 (2019).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10702_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","volume":"10","author":"PS Tofts","year":"1999","unstructured":"Tofts, P. S. et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: Standardized quantities and symbols. J. Magn. Reson. Imaging 10, 223\u2013232 (1999).","journal-title":"J. Magn. Reson. Imaging"},{"key":"10702_CR39","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/bcp.13280","volume":"83","author":"TA Althunian","year":"2017","unstructured":"Althunian, T. A., de Boer, A., Groenwold, R. H. H. & Klungel, O. H. Defining the noninferiority margin and analysing noninferiority: An overview. Br. J. Clin. Pharmacol. 83, 1636\u20131642 (2017).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10702_CR40","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/sj.bjc.6603140","volume":"94","author":"B Morgan","year":"2006","unstructured":"Morgan, B. et al. A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br. J. Cancer 94, 1420\u20131427 (2006).","journal-title":"Br. J. Cancer"},{"key":"10702_CR41","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2214\/AJR.21.25924","volume":"217","author":"BP Liu","year":"2021","unstructured":"Liu, B. P. et al. Clinical efficacy of reduced-dose gadobutrol versus standard-dose gadoterate for contrast-enhanced MRI of the CNS: An international multicenter prospective crossover trial (LEADER-75). AJR Am. J. Roentgenol. 217, 1195\u20131205 (2021).","journal-title":"AJR Am. J. Roentgenol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10702-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:16:22Z","timestamp":1757272582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10702-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10702"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10702-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26419"}}